EDC for single-site clinical trials: one site, one platform, 21 CFR Part 11–aligned controls and audit trails without multi-site complexity.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
When your entire study runs at one site, every inefficiency is amplified. A coordinator toggling between separate systems for consent, data entry, and safety reporting loses time that could be spent on participant care and enrollment. An investigator who needs to check enrollment status in one tool and data quality in another loses visibility into their own study. With Capture, single-site teams work from one system for every operational task. This single-platform approach is particularly valuable for investigator-initiated research (IIR) at academic medical centers, where the investigator is often both the scientific lead and the operational sponsor. Having one login, one dashboard, and one audit trail simplifies the investigator oversight responsibilities and makes it straightforward to demonstrate compliance to IRBs and sponsors. Coordinators benefit from a consistent data entry experience across all assessment types—CRFs, consent, ePRO, and safety—which reduces training time and data entry errors.
Many successful single-site studies lead to multi-site expansion. A pilot study at one academic center may demonstrate promising results that justify a multi-center Phase 2. A device feasibility study at a single site may advance to a pivotal trial across several hospitals. When this happens, teams that built their original study on a purpose-built EDC platform have a significant advantage: they do not need to migrate data, revalidate a new system, or retrain their original site. Capture is designed with this growth trajectory in mind. The same CRF designs, consent templates, visit structures, and role definitions that worked for your single-site study can be extended to additional sites. New sites receive their own role-based access within the same study build, and the audit trail remains continuous and unified. This continuity matters for regulatory submissions, where consistent data provenance across study phases strengthens your package.
Regulatory expectations for data integrity do not scale down with site count. A single-site Phase 1 study at an academic center is held to the same 21 CFR Part 11 expectations as a global Phase 3 program when it comes to audit trails, electronic signatures, and access control. This means that even for small, focused studies, your EDC must provide a tamper-evident record of every data entry, modification, and signature event. Capture provides this level of compliance out of the box. Every CRF field change is logged with a timestamp, user identity, and reason for change. Electronic signatures meet the requirements outlined in 21 CFR Part 11 for attributability and non-repudiation. Role-based access ensures that coordinators, investigators, monitors, and data managers can only perform actions appropriate to their role. For studies that require formal validation (typically sponsor-mandated regulated trials), Capture provides documentation and support for installation qualification (IQ), operational qualification (OQ), and user acceptance testing (UAT) through the Enterprise tier.
Overview
Single-site clinical trials keep operations lean: one investigator site, one study team, and a focused need for electronic data capture that supports consent, CRFs, safety, and optional patient-reported outcomes with full auditability—without multi-site overhead. These studies are common across academic medical centers running investigator-initiated research, biotech sponsors conducting early-phase work at a single center of excellence, and device companies performing first-in-human evaluations at a specialized facility. While the operational footprint is smaller than a multi-center program, the regulatory expectations are the same. Data must be captured with a complete audit trail, electronic signatures must be 21 CFR Part 11–aligned, and participant privacy must be protected in accordance with HIPAA-aligned security controls. Sponsors, IRBs, and health authorities expect the same standards regardless of whether the study spans one site or fifty. Your system should be straightforward to build and use. Coordinators at a single site should not need weeks of training to enter data. Investigators should be able to review their study progress without navigating layers of multi-site hierarchy. And the study team should be able to export clean, analysis-ready data without waiting on a central programming group. Capture provides EDC, eConsent, ePRO, and safety in one platform with role-based access and audit trails, so single-site studies run smoothly without the cost and complexity of enterprise multi-site systems. Capture is also designed with growth in mind. If your single-site study succeeds and you expand to additional sites for a follow-on protocol, the same platform, CRF designs, consent templates, and audit trail infrastructure scale with you—no migration, no revalidation of a different system.
Single-site studies do not need multi-site dashboards, complex site hierarchies, or global monitoring workflows—but you do need one system that handles consent, data capture, safety reporting, and optional ePRO with clear audit trails and access controls. Enterprise EDC platforms are often designed for large, multi-regional trials: they come with pricing models based on site count, feature sets built for global coordination, and implementation timelines that assume a large project team. For a single-site study, this creates misalignment between what you need and what you are paying for. At the same time, cutting corners with spreadsheets, paper CRFs, or generic survey tools introduces compliance risks that can jeopardize your data. Regulators, sponsors, and ethics committees expect the same level of auditability and data integrity from single-site studies as from multi-center programs. This means you need electronic signatures, role-based access, and a tamper-evident audit trail—without the overhead of an enterprise platform. Capture is built for studies of any size: one site or many, with the same 21 CFR Part 11–aligned controls and HIPAA-aligned security. The platform gives single-site teams a right-sized solution: fast to set up, simple to use, fully compliant, and ready to scale if the research program grows. Because all modules (EDC, eConsent, ePRO, safety) are integrated, you avoid the fragmentation of patching together separate tools for different data types.
FAQ
Explore the platform with a free sandbox. No sales call required.